Glucosado Soro Isotónico B.Braun Medical

Glucosado Soro Isotónico B.Braun Medical is an intravenous solution for injection that contains glucose monohydrate as its active ingredient. The product’s strength is not specified on the label, and it is supplied as a sterile isotonic carbohydrate solution intended for parenteral use in clinical settings across the EU.

Glucosado Soro Isotónico is indicated for several clinical situations where rapid glucose supplementation or fluid replacement is required.

- Treatment of hypoglycemia when oral intake is not feasible. - Part of parenteral nutrition regimens to provide an energy source. - Fluid and electrolyte replacement in patients unable to receive oral fluids. - Support during perioperative care to maintain plasma glucose levels. - Adjunct therapy in critical care for patients with increased metabolic demand.

Side effects may vary in frequency and severity. Patients should be monitored for any adverse reactions during and after administration.

Common: - Local irritation at the infusion site. - Mild hyperglycemia. - Electrolyte imbalance, such as low potassium. - Nausea or vomiting. - Headache.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Allergic reaction or anaphylaxis. - Phlebitis or thrombophlebitis. - Fluid overload, especially in patients with cardiac or renal impairment. - Metabolic acidosis in susceptible individuals.

Glucosado Soro Isotónico should be used with careful clinical assessment and monitoring.

- Verify patient’s blood glucose level before infusion. - Adjust infusion rate in patients with renal or cardiac failure to avoid fluid overload. - Use caution in diabetic patients; monitor glucose closely. - Ensure compatibility with other intravenous solutions; do not mix with incompatible drugs. - Store according to manufacturer’s instructions, protecting from light and extreme temperatures. - Discard any solution that appears discolored or contains particles.

Glucosado Soro Isotónico may interact with other medications or clinical conditions.

Avoid: - Co-administration with high-dose insulin without glucose monitoring. - Use with potassium-sparing diuretics in patients prone to hyperkalemia. - Simultaneous infusion with drugs that precipitate in high-glucose solutions.

Use with caution: - Concurrent administration of other carbohydrate-containing IV fluids. - Patients receiving glucocorticoids, which may raise glucose levels. - Medications that affect renal function, such as NSAIDs. - Drugs that alter electrolyte balance, like loop diuretics.